Comparison of CLEIA and ELISA for SARS-CoV-2 Virus Antibodies after First and Second Dose Vaccinations with the BNT162b2 mRNA Vaccine

The global severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has required rapid action to control its spread and vaccines are a fundamental solution to this pandemic. The development of rapid and reliable serological tests to monitor the antibody response to coronavirus disease v...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashenagar, Mohammad Said, Matsumoto, Akiko, Sakai, Hironori, Tokiya, Mikiko, Hara, Megumi, Hirota, Yoshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033149/
https://www.ncbi.nlm.nih.gov/pubmed/35455236
http://dx.doi.org/10.3390/vaccines10040487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033149/
https://www.ncbi.nlm.nih.gov/pubmed/35455236
http://dx.doi.org/10.3390/vaccines10040487

Ejemplares similares